Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Rani Therapeutics today announced a $69 million round to fund development ...
The list of biologics seems to be growing by the day. But biologics fall short of potentially reaching millions of patients because there hasn’t been a way to encapsulate them in a pill for mass ...
Shire and Rani Therapeutics Enter into Collaboration to Evaluate Use of the Rani Pill(TM) Technology for the Oral Delivery of Factor Therapy Shire obtains exclusive rights to conduct research on, ...
Rani Therapeutics has secured $69 million in new funding to move forward with the manufacturing and clinical testing of its “robotic pill”—a small, swallowable capsule that promises to shepherd more ...
While raking in $73 million for an initial public offering isn’t exactly a tough pill to swallow, it does clock in quite a bit below the $100 million Rani Therapeutics originally planned to earn in ...
SAN JOSE, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral ...
Startup Rani Therapeutics LLC has gotten positive safety results in a first-in-human trial of its pill that's designed to enable painless injections of biologic drugs into the small intestine. Later ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results